| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | 437,2 k € | +47.5% | 296,3 k € | +78.9% | 165,6 k € | — | 137,0 k € | +4.1% | 131,6 k € | |||||||||||||||
| Gross margin | 701,9 k € | +34.9% | 520,5 k € | -4.5% | 545,0 k € | +2.3% | 533,0 k € | -34.1% | 809,1 k € | +33.7% | 605,2 k € | +57.7% | 383,9 k € | +37.9% | 278,3 k € | -9.6% | 307,9 k € | -20.8% | 388,6 k € | +3.5% | 375,6 k € | +65.0% | 227,6 k € | +8.6% | 209,6 k € | +101.1% | 104,2 k € | +300.3% | 26,0 k € | -70.1% | 87,1 k € | +122.9% | 39,1 k € | +66.4% | 23,5 k € | |
| EBITDA | 376,5 k € | +100.2% | 188,0 k € | -39.1% | 309,0 k € | -13.4% | 356,7 k € | -38.1% | 576,4 k € | +53.0% | 376,6 k € | +80.0% | 209,2 k € | +44.6% | 144,7 k € | +155.9% | 56,6 k € | -71.4% | 197,4 k € | -0.9% | 199,1 k € | +143.5% | 81,8 k € | -31.1% | 118,7 k € | +418.4% | 22,9 k € | +3.4% | 22,2 k € | -74.0% | 85,3 k € | +126.7% | 37,6 k € | +73.5% | 21,7 k € | |
| Operating profit | 258,9 k € | +391.2% | 52,7 k € | -69.3% | 171,9 k € | -24.5% | 227,7 k € | -50.7% | 462,0 k € | +73.8% | 265,9 k € | +159.7% | 102,4 k € | +117.7% | 47,0 k € | +136.9% | -127,5 k € | -221.1% | 105,3 k € | -15.7% | 124,9 k € | +675.5% | 16,1 k € | +161.9% | -26,0 k € | -481.9% | 6,8 k € | -51.9% | 14,1 k € | -80.1% | 70,9 k € | +531.6% | 11,2 k € | +280.8% | -6,2 k € | |
| Profit/loss | 110,9 k € | +177.7% | -142,6 k € | -676.2% | 24,8 k € | -78.9% | 117,4 k € | -72.1% | 420,9 k € | +118.1% | 193,0 k € | +2768.6% | -7,2 k € | +96.9% | -231,8 k € | +11.5% | -261,9 k € | -462.6% | 72,2 k € | +33.8% | 54,0 k € | +503.8% | -13,4 k € | +65.0% | -38,2 k € | -10051.6% | 384,2 € | -99.5% | 70,3 k € | +51.6% | 46,3 k € | +290.9% | 11,9 k € | +86.9% | 6,3 k € | |
| Equity | 431,7 k € | +34.5% | 320,9 k € | -30.8% | 463,5 k € | +5.6% | 438,8 k € | +36.6% | 321,3 k € | +422.8% | -99,5 k € | +66.0% | -292,5 k € | -2.5% | -285,3 k € | -433.5% | -53,5 k € | -125.7% | 208,4 k € | +102.8% | 102,8 k € | +110.7% | 48,8 k € | -21.5% | 62,2 k € | -38.1% | 100,4 k € | +0.4% | 100,0 k € | +139.3% | 41,8 k € | -56.2% | 95,5 k € | +14.2% | 83,6 k € | |
| Total assets | 1,5 M € | -9.6% | 1,6 M € | -5.9% | 1,7 M € | -5.0% | 1,8 M € | -6.5% | 1,9 M € | +24.9% | 1,6 M € | -6.6% | 1,7 M € | +19.3% | 1,4 M € | -18.0% | 1,7 M € | +63.6% | 1,0 M € | +11.5% | 934,0 k € | +32.3% | 705,9 k € | +1.1% | 698,1 k € | +243.6% | 203,2 k € | -1.0% | 205,1 k € | -47.6% | 391,3 k € | +6.9% | 366,1 k € | +3.2% | 354,8 k € | |
| Cash | 0,0 € | -100.0% | 1,5 k € | -83.7% | 9,0 k € | -83.3% | 54,0 k € | +108.5% | 25,9 k € | +28.0% | 20,2 k € | +3.9% | 19,5 k € | +304.9% | 4,8 k € | -84.0% | 30,0 k € | +25.9% | 23,8 k € | +3.0% | 23,1 k € | +240.7% | 6,8 k € | -50.1% | 13,6 k € | -88.8% | 121,8 k € | -20.4% | 153,0 k € | -24.6% | 202,9 k € | +7711.6% | 2,6 k € | +1513.0% | 161,0 € | |
| Debts | 1,0 M € | -20.5% | 1,3 M € | +3.2% | 1,3 M € | -8.4% | 1,4 M € | -15.0% | 1,6 M € | -2.0% | 1,7 M € | -15.4% | 2,0 M € | +22.3% | 1,6 M € | -0.1% | 1,6 M € | +99.1% | 804,7 k € | +0.8% | 798,2 k € | +28.4% | 621,8 k € | +4.0% | 598,1 k € | +871.4% | 61,6 k € | -5.2% | 65,0 k € | -81.4% | 349,5 k € | +29.1% | 270,7 k € | -0.2% | 271,1 k € | |
| Staff | 5,6 | 6,1 | 3,3 | 3,3 | 3,7 | 5,8 | 6,2 | 6,4 | 6,5 | 5 | 4,1 | 2,6 | 2,1 | 1,5 | — | — | — | — | ||||||||||||||||||
Private limited company · Uccle · incorporated on 15/02/2002 · 5,6 ETP
Private limited company profitable and well capitalised. Cash position declining (-100.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDIKEMOS is a Private limited company incorporated in 2002. Its main activity is: Hospital activities. Its registered office is in Uccle. It employs on average 5,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette